用复合乳糖杆菌 (Lactococcus lactis) 制备的基于树突细胞的疫苗通过ROS生产增强了抗原交叉呈现和抗瘤疗效

Tingting Zhang1, Xianxian Wei1, Yijie Li1

  • 1Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, China.

Frontiers in immunology
|September 15, 2023
PubMed
概括

乳球菌增强树突细胞活化和抗瘤免疫力. 这种安全的载体为改善交叉呈现和T细胞反应提供抗原,显著抑制瘤生长.